Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).
Singh M, Joshi S, Vohra V, Sarin R, Kamble SV, Velayutham B, Mohan A, Singh UB, Kumar R, Pati S, Pattnaik M, Mohapatra PR, Shankar U, Narasimhaiah S, Yadav G, Hissar S, Rodrigues R, Kadam AV, Paramasivam PK, Kambhampati S, Newtonraj A, Palaniappan NA, Reddy SD, Bhuniya S, Mishra BK, Shete A, Hanna LE, Mitra DK, Panda S, Guleria R, Tripathy S, Roy N, D'Souza G, Tripathy SK, Katoch K, Pandey RM, Sah S, Kashyap M, Telasey V, Bakshi M, Wadhwa N, Khan AM, Gangakhedkar RR, Rani R.
Singh M, et al. Among authors: palaniappan na.
BMJ. 2026 Apr 9;393:e085716. doi: 10.1136/bmj-2025-085716.
BMJ. 2026.
PMID: 41962942
Free PMC article.
Clinical Trial.